Effectiveness of a mobile application for tracking symptoms and enhancing symptom management among breast cancer patients receiving chemotherapy in Bangkok, Thailand: a non-randomized controlled trial
5
Issued Date
2025-05-01
Resource Type
ISSN
20053673
eISSN
2093758X
Scopus ID
2-s2.0-105008394754
Journal Title
Journal of Korean Academy of Nursing
Volume
55
Issue
2
Start Page
178
End Page
190
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Korean Academy of Nursing Vol.55 No.2 (2025) , 178-190
Suggested Citation
Kaveenuntachai D., Jaiboon S., Sumdaengrit B., Silaguntsuti C., Vittayatigonnasak A., Sailamai P. Effectiveness of a mobile application for tracking symptoms and enhancing symptom management among breast cancer patients receiving chemotherapy in Bangkok, Thailand: a non-randomized controlled trial. Journal of Korean Academy of Nursing Vol.55 No.2 (2025) , 178-190. 190. doi:10.4040/jkan.25011 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/110917
Title
Effectiveness of a mobile application for tracking symptoms and enhancing symptom management among breast cancer patients receiving chemotherapy in Bangkok, Thailand: a non-randomized controlled trial
Corresponding Author(s)
Other Contributor(s)
Abstract
Purpose: This study evaluated the effectiveness of a mobile application in tracking symptoms and improving symptom management and quality of life (QoL) among breast cancer patients undergoing chemotherapy in Thailand. Methods: A non-randomized controlled trial was used, with 25 participants in the intervention group and 25 in the control group. Research instruments included a demographic data form, the NCI-PRO-CTCAE Items-Thai-Thailand version 1.0, and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire and Breast Cancer-Specific Module. Results: The intervention group had significantly less severe side effects than the control group, with mean differences of –23.33 (95% confidence interval [CI], –27.82 to –18.83) on day 1, –28.18 (95% CI, –33.22 to –23.14) on day 3, –34.63 (95% CI, –40.18 to –29.08) on day 7, –42.56 (95% CI, –48.72 to –36.40) on day 14, and –51.31 (95% CI, –58.13 to –44.48) on day 21 (p<.001 for all). On day 21, participants in the intervention group reported significantly higher scores in the Global Health QoL and Functional Scales compared to the control group (p<.001). Additionally, intervention group participants reported lower scores on the Symptom Scales and higher scores on the Functional Scales than those in the control group (p<.001). Conclusion: The ChemoPro application helped manage chemotherapy-related symptoms and was associated with improved symptom monitoring and QoL. Nonetheless, the study was limited by a small sample size and restriction to Android users. Future research with larger and more diverse populations is recommended before broader implementation in clinical practice.